Lipids in Health and Disease

The requirement of cholesterol for internalization of eukaryotic pathogens like protozoa (Leishmaniasis, Malaria and Toxoplasmosis) and the exchange of cholesterol along with other metabolites during reproduction in Schistosomes (helminths) under variable circumstances are poorly understood. In patients infected with some other helminthes, alterations in the lipid profile have been observed. Also, the mechanisms involved in lipid changes especially in membrane proteins related to parasite infections remain uncertain. Present review of literature shows that parasites induce significant changes in lipid parameters, as has been shown in the in vitro study where substitution of serum by lipid/cholesterol in medium and in experimental models (in vivo). Thus changes in lipid profile occur in patients having active infections with most of the parasites. Membrane proteins are probably involved in such reactions. All parasites may be metabolising cholesterol, but the exact relationship with pathogenic mechanism is not clear. So far, studies suggest that there may be some factors or enzymes, which allow the parasite to breakup and consume lipid/cholesterol. Further studies are needed for better understanding of the mechanisms involved in vivo. The present review analysis the various studies till date and the role of cholesterol in pathogenesis of different parasitic infections. Introduction Parasitic protozoa and helminthes are responsible for some of the most devastating and prevalent diseases of humans, threatening the lives of nearly one-third of the worldwide human population leading to more than 2 million deaths annually. Habitats of parasites are extremely varied and common parasites of man (protozoa, helminthes and arthropods) normally inhabit the intestine, blood, liver, lungs brain, muscles and lymphatic tissues [1]. Many species of parasites have complex life cycles involving developmental stages that live in soil or water, or use various kinds of intermediate hosts, including vertebrates and invertebrates and cold and warmblooded animals. In such varied environments, parasites have become adapted to using/tolerating widely differing oxygen, carbon dioxide, hydrogen ion concentrations and temperatures [1]. Their nutritional requirements and their means of obtaining and utilizing the nutrients required for growth, motility and reproduction are also varied. The requirement of cholesterol for internalization of eukaryotic pathogens under such variable circumstances is poorly understood. Published: 09 May 2005 Lipids in Health and Disease 2005, 4:10 doi:10.1186/1476-511X-4-10 Received: 16 March 2005 Accepted: 09 May 2005 This article is available from: http://www.lipidworld.com/content/4/1/10 © 2005 Bansal et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

[1]  S. Yusuf,et al.  Epidemiology and causation of coronary heart disease and stroke in India , 2007, Heart.

[2]  M. Pencina,et al.  Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. , 2007, JAMA.

[3]  C. Gieger,et al.  Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.

[4]  Rajeev Gupta,et al.  Trends in prevalence of coronary risk factors in an urban Indian population: Jaipur Heart Watch-4. , 2007, Indian heart journal.

[5]  V. Thijs,et al.  Lipoprotein (a) and Stroke: A Meta-Analysis of Observational Studies , 2007, Stroke.

[6]  B. Nordestgaard,et al.  Improving Prediction of Ischemic Cardiovascular Disease in the General Population Using Apolipoprotein B: The Copenhagen City Heart Study , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[7]  S. Yusuf,et al.  Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. , 2007, JAMA.

[8]  V. Hazarey,et al.  Oral submucous fibrosis: study of 1000 cases from central India. , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[9]  C. Heward,et al.  Disparate LDL phenotypic classification among 4 different methods assessing LDL particle characteristics. , 2006, Clinical chemistry.

[10]  R. Bahr,et al.  Promoting Physical Activity in a Low-Income Multiethnic District: Effects of a Community Intervention Study to Reduce Risk Factors for Type 2 Diabetes and Cardiovascular Disease , 2006, Diabetes Care.

[11]  E. Boerwinkle,et al.  Quantitative trait loci influencing low density lipoprotein particle size in African Americans Published, JLR Papers in Press, April 19, 2006. , 2006, Journal of Lipid Research.

[12]  Takashi Saku,et al.  Oral submucous fibrosis: review on aetiology and pathogenesis. , 2006, Oral oncology.

[13]  Rajeev Gupta,et al.  Smoking, educational status and health inequity in India. , 2006, The Indian journal of medical research.

[14]  Miyong T. Kim,et al.  Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey. , 2006, International journal of cardiology.

[15]  P. Jeemon,et al.  Methods for establishing a surveillance system for cardiovascular diseases in Indian industrial populations. , 2006, Bulletin of the World Health Organization.

[16]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[17]  J. Mckenney,et al.  Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia. , 2006, Journal of the American College of Cardiology.

[18]  N. Chalasani,et al.  An assessment of statin safety by hepatologists. , 2006, The American journal of cardiology.

[19]  P. Thompson,et al.  An assessment of statin safety by muscle experts. , 2006, The American journal of cardiology.

[20]  Paul Scheet,et al.  A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. , 2006, American journal of human genetics.

[21]  R. Krauss,et al.  Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel , 2006, Journal of internal medicine.

[22]  R. D'Agostino,et al.  Search for an optimal atherogenic lipid risk profile: from the Framingham Study. , 2006, The American journal of cardiology.

[23]  T. Gaziano,et al.  Cardiovascular Disease in the Developing World and Its Cost-Effective Management , 2005, Circulation.

[24]  E. Bruckert,et al.  Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study , 2005, Cardiovascular Drugs and Therapy.

[25]  Bela Shah,et al.  Responding to the threat of chronic diseases in India , 2005, The Lancet.

[26]  P. Sorlie,et al.  Trends in serum lipids and lipoproteins of adults, 1960-2002. , 2005, JAMA.

[27]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[28]  K. Kandror,et al.  Sortilin is essential and sufficient for the formation of Glut4 storage vesicles in 3T3-L1 adipocytes. , 2005, Developmental cell.

[29]  M. Rhodes,et al.  Assessment of two flexible and compatible SNP genotyping platforms: TaqMan SNP Genotyping Assays and the SNPlex Genotyping System. , 2005, Mutation research.

[30]  R. Bhopal,et al.  Is coronary heart disease rising in India? A systematic review based on ECG defined coronary heart disease , 2005, Heart.

[31]  D. Stojanovski,et al.  Dissection of the Mitochondrial Import and Assembly Pathway for Human Tom40* , 2005, Journal of Biological Chemistry.

[32]  S. Yamashita,et al.  Identification of Unique Lipoprotein Subclasses for Visceral Obesity by Component Analysis of Cholesterol Profile in High-Performance Liquid Chromatography , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[33]  G. Dagenais,et al.  Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in Men: 13-Year Follow-Up Data From the Québec Cardiovascular Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[34]  D. Bansal,et al.  Altered lipid parameters in patients infected with Entamoeba histolytica, Entamoeba dispar and Giardia lamblia , 2005, British journal of biomedical science.

[35]  Rajeev Gupta,et al.  High prevalence of multiple coronary risk factors in Punjabi Bhatia community: Jaipur Heart Watch-3. , 2004, Indian heart journal.

[36]  R. Powell,et al.  Involvement of Raft-Like Plasma Membrane Domains of Entamoeba histolytica in Pinocytosis and Adhesion , 2004, Infection and Immunity.

[37]  B. Devlin,et al.  ADLAPH: A molecular haplotyping method based on allele-discriminating long-range PCR. , 2004, Genomics.

[38]  Alexander F. Wilson,et al.  Genetics of ultrasonographic carotid atherosclerosis. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[39]  W. Willett,et al.  Physical activity and risk of coronary heart disease in India. , 2004, International journal of epidemiology.

[40]  K. Reynolds,et al.  Serum Total and Lipoprotein Cholesterol Levels and Awareness, Treatment, and Control of Hypercholesterolemia in China , 2004, Circulation.

[41]  J. Fruchart,et al.  Pharmacodynamic and pharmaco-kinetic interaction between fenofibrate and ezetimibe* , 2004, Current medical research and opinion.

[42]  D. Ferguson,et al.  Light and electron microscopical observations of the effects of high-density lipoprotein on growth of Plasmodium falciparum in vitro , 2004, Parasitology.

[43]  M. Leippe,et al.  Membrane lipid composition protects Entamoeba histolytica from self‐destruction by its pore‐forming toxins , 2004, FEBS letters.

[44]  S. Koba,et al.  Clinical Significance of Small Dense Low-Density Lipoprotein Cholesterol Levels Determined by the Simple Precipitation Method , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[45]  T. McDade,et al.  High-sensitivity enzyme immunoassay for C-reactive protein in dried blood spots. , 2004, Clinical chemistry.

[46]  R. Madhubala,et al.  Cholesterol is required for Leishmania donovani infection: implications in leishmaniasis. , 2004, Molecular and biochemical parasitology.

[47]  R. Gupta,et al.  Trends in hypertension epidemiology in India , 2004, Journal of Human Hypertension.

[48]  Toshihiro Tanaka The International HapMap Project , 2003, Nature.

[49]  L. Cattin,et al.  Production of polyacrylamide gradient gel for lipoprotein electrophoretic separation. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[50]  Tsutomu Hirano,et al.  A novel and simple method for quantification of small, dense LDL Published, JLR Papers in Press, August 1, 2003. DOI 10.1194/jlr.D300007-JLR200 , 2003, Journal of Lipid Research.

[51]  I. Coppens,et al.  Host but not parasite cholesterol controls Toxoplasma cell entry by modulating organelle discharge. , 2003, Molecular biology of the cell.

[52]  O. Akinboboye,et al.  Trends in coronary artery disease and associated risk factors in sub-Saharan Africans , 2003, Journal of Human Hypertension.

[53]  P. Sager,et al.  Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia: A Prospective, Randomized, Double-Blind Trial , 2003, Circulation.

[54]  R. Suresh,et al.  Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. , 2003, European heart journal.

[55]  H. Vial,et al.  Phospholipids in parasitic protozoa. , 2003, Molecular and biochemical parasitology.

[56]  P. Wolf,et al.  Genetic and Environmental Contributions to Atherosclerosis Phenotypes in Men and Women: Heritability of Carotid Intima-Media Thickness in the Framingham Heart Study , 2003, Stroke.

[57]  J. Raper,et al.  Evidence for a Trypanosoma brucei Lipoprotein Scavenger Receptor* , 2003, The Journal of Biological Chemistry.

[58]  D. Blom,et al.  Non-denaturing polyacrylamide gradient gel electrophoresis for the diagnosis of dysbetalipoproteinemia Published, JLR Papers in Press, September 1, 2002. DOI 10.1194/jlr.D200013-JLR200 , 2003, Journal of Lipid Research.

[59]  Barry R. Davis,et al.  Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). , 2002, JAMA.

[60]  B. Howard,et al.  Heritability of Carotid Artery Structure and Function: The Strong Heart Family Study , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[61]  S. Grundy,et al.  ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins. , 2002, Circulation.

[62]  R. Krauss,et al.  Metabolic origins and clinical significance of LDL heterogeneity DOI 10.1194/jlr.R200004-JLR200 , 2002, Journal of Lipid Research.

[63]  Frederick R Maxfield,et al.  Plasma membrane microdomains. , 2002, Current opinion in cell biology.

[64]  B. Ramjattan,et al.  Efficacy and tolerability of a "suprabioavailable" formulation of fenofibrate in patients with dyslipidemia: a pooled analysis of two open-label trials. , 2002, Clinical therapeutics.

[65]  C. Langefeld,et al.  Heritability of Carotid Artery Intima-Medial Thickness in Type 2 Diabetes , 2002, Stroke.

[66]  P. Kremsner,et al.  The impact of malaria on common lipid parameters , 2002, Parasitology Research.

[67]  S. Thompson,et al.  How should meta‐regression analyses be undertaken and interpreted? , 2002, Statistics in medicine.

[68]  Alethia Villasenõr,et al.  Lipid metabolism in mucous-dwelling amitochondriate protozoa. , 2002, International journal for parasitology.

[69]  M. Doenhoff,et al.  An anti-atherogenic effect of Schistosoma mansoni infections in mice associated with a parasite-induced lowering of blood total cholesterol , 2002, Parasitology.

[70]  O. Raitakari,et al.  Population-Based Twin Study of the Effects of Migration From Finland to Sweden on Endothelial Function and Intima-Media Thickness , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[71]  M. Attias,et al.  Ultrastructural and Biochemical Alterations Induced by 22,26-Azasterol, a Δ24(25)-Sterol Methyltransferase Inhibitor, on Promastigote and Amastigote Forms of Leishmania amazonensis , 2002, Antimicrobial Agents and Chemotherapy.

[72]  G. Dagenais,et al.  Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. , 2001, Archives of internal medicine.

[73]  G. Dagenais,et al.  Comparison of Various Electrophoretic Characteristics of LDL Particles and Their Relationship to the Risk of Ischemic Heart Disease , 2001, Circulation.

[74]  Robert V Farese,et al.  Cholesterol Esterification by Host and Parasite Is Essential for Optimal Proliferation of Toxoplasma gondii * , 2001, The Journal of Biological Chemistry.

[75]  D. Kaul,et al.  Receptor‐Ck regulates giardia encystation process , 2001, Molecular and Cellular Biochemistry.

[76]  V. Mohan,et al.  Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: The Chennai Urban Population Study (CUPS No. 5). , 2001, Journal of the American College of Cardiology.

[77]  R. Bedi,et al.  Oral submucous fibrosis in a 11-year-old Bangladeshi girl living in the United Kingdom , 2001, British Dental Journal.

[78]  C. Aguilar-Salinas,et al.  High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. , 2001, Journal of lipid research.

[79]  R. D. Adam,et al.  Biology of Giardia lamblia , 2001, Clinical Microbiology Reviews.

[80]  L. Ramakrishnan,et al.  Measurement of cholesterol and triglycerides in dried serum and the effect of storage. , 2001, Clinical chemistry.

[81]  J V Mei,et al.  Use of filter paper for the collection and analysis of human whole blood specimens. , 2001, The Journal of nutrition.

[82]  J. Mcconnell,et al.  Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. , 2001, Clinical chemistry.

[83]  P. Wolf,et al.  Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. , 2001, Circulation.

[84]  Kai Simons,et al.  Lipid rafts and signal transduction , 2000, Nature Reviews Molecular Cell Biology.

[85]  J. Danesh,et al.  Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies , 2000, Circulation.

[86]  E. Vartiainen,et al.  Changes in cardiovascular risk factors in different socioeconomic groups: seven year trends in a Chinese urban population , 2000, Journal of epidemiology and community health.

[87]  P. Donnelly,et al.  Inference of population structure using multilocus genotype data. , 2000, Genetics.

[88]  I. Coppens,et al.  Toxoplasma gondii Exploits Host Low-Density Lipoprotein Receptor-Mediated Endocytosis for Cholesterol Acquisition , 2000, The Journal of cell biology.

[89]  S. Reed,et al.  Cysteine proteinases and the pathogenesis of amebiasis. , 2000, Clinical microbiology reviews.

[90]  D. Kaul,et al.  Molecular basis of cholesterol feedback lesion in CNS tumours. , 2000, Neurology India.

[91]  A. Raza,et al.  The clinical and biologic significance of abnormal lipid profiles in patients with myelodysplastic syndromes. , 2000, Journal of hematotherapy & stem cell research.

[92]  D. Kaul,et al.  Receptor-Ck regulates the expression of cyclin-dependent kinase inhibitors (p16; p27) , 1999, Molecular and Cellular Biochemistry.

[93]  A. Folsom,et al.  Relative importance of various risk factors for asymptomatic carotid atherosclerosis versus coronary heart disease incidence: the Atherosclerosis Risk in Communities Study. , 1999, American journal of epidemiology.

[94]  G. Olivecrona,et al.  Sortilin/Neurotensin Receptor-3 Binds and Mediates Degradation of Lipoprotein Lipase* , 1999, The Journal of Biological Chemistry.

[95]  A. Gotto Triglyceride as a risk factor for coronary artery disease. , 1998, The American journal of cardiology.

[96]  B. Barone,et al.  Cholesterolemia in colorectal cancer. , 1998, Hepato-gastroenterology.

[97]  J. Cook,et al.  An assessment of dried blood-spot technology for identifying iron deficiency. , 1998, Blood.

[98]  M. Aikawa,et al.  The prime role of plasma membrane cholesterol in the pathogenesis of immune evasion and clinical manifestations of falciparum malaria. , 1998, Medical hypotheses.

[99]  G. Siest,et al.  Genetics strongly determines the wall thickness of the left and right carotid arteries , 1998, Human Genetics.

[100]  C. Brotons,et al.  Worldwide distribution of blood lipids and lipoproteins in childhood and adolescence: a review study. , 1998, Atherosclerosis.

[101]  J. Guevara-Aguirre,et al.  Filter paper blood spot assay of human insulin-like growth factor I (IGF-I) and IGF-binding protein-3 and preliminary application in the evaluation of growth hormone status. , 1998, The Journal of clinical endocrinology and metabolism.

[102]  D. Kaul Receptor-Ck and leukemogenesis. , 1998, Leukemia research.

[103]  C. Sudlow,et al.  Investigating individual subjects and screening populations for asymptomatic carotid stenosis can be harmful , 1998, Journal of neurology, neurosurgery, and psychiatry.

[104]  R. Sobti,et al.  Receptor-Ck-dependent regulation of genes involved in the cell cycle , 1998, Molecular and Cellular Biochemistry.

[105]  D. Hunninghake,et al.  Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study) , 1998, The American journal of cardiology.

[106]  I. Kimata,et al.  Heterogeneous Distribution of Membrane Cholesterol at the Attachment Site of Cryptosporidium muris to Host Cells , 1997, The Journal of eukaryotic microbiology.

[107]  T. Nash,et al.  Mechanisms of Giardia Lamblia Differentiation Mechanisms of Giardia Lamblia Differentiation into Cysts , 2022 .

[108]  W. Shelledy,et al.  Characterization of a composite gradient gel for the electrophoretic separation of lipoproteins. , 1997, Journal of lipid research.

[109]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[110]  W. Powers,et al.  Cost-effectiveness of screening for asymptomatic carotid atherosclerotic disease. , 1997, Stroke.

[111]  V. Kaul,et al.  Cholesterol lipoproteins, triglycerides, rural-urban differences and prevalence of dyslipidaemia among males in Rajasthan. , 1997, The Journal of the Association of Physicians of India.

[112]  R. Krauss,et al.  A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. , 1996, JAMA.

[113]  S. Said-Fernández,et al.  PACSR: a serum replacement for axenic cultivation of Entamoeba histolytica. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[114]  J. Hokanson,et al.  Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[115]  T. Nash,et al.  Lipid Requirements and Lipid Uptake by Giardia lamblia Trophozoites in Culture , 1996, The Journal of eukaryotic microbiology.

[116]  P. J. Johnson,et al.  Identification and characterization of [Fe]-hydrogenases in the hydrogenosome of Trichomonas vaginalis. , 1996, Molecular and biochemical parasitology.

[117]  D. S. Reiner,et al.  A Lipoprotein‐Cholesterol‐Albumin Serum Substitute Stimulates Giardia lamblia Encystation Vesicle Formation , 1995, The Journal of eukaryotic microbiology.

[118]  A. von Eckardstein,et al.  Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[119]  Satyavan Sharma,et al.  Prevalence of coronary heart disease and coronary risk factors in an urban population of Rajasthan. , 1995, Indian heart journal.

[120]  M. Koschinsky,et al.  Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). , 1995, Clinical chemistry.

[121]  V. Gupta,et al.  Educational status, coronary heart disease, and coronary risk factor prevalence in a rural population of India , 1994, BMJ.

[122]  S. Srivastava Liver plasma membrane-bound enzymes and lipids in golden hamsters infected with Ancylostoma ceylanicum. , 1994, International journal for parasitology.

[123]  J. Berman,et al.  Treatment of Brazilian kala-azar with a short course of amphocil (amphotericin B cholesterol dispersion). , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[124]  A. Thomson,et al.  Lipid absorption: passing through the unstirred layers, brush-border membrane, and beyond. , 1993, Canadian journal of physiology and pharmacology.

[125]  T. Davis,et al.  Platelet-activating factor and lipid metabolism in acute malaria. , 1993, The Journal of infection.

[126]  J. Hokanson,et al.  Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[127]  N. Ganguly,et al.  An experimental model of ameboma in guinea pig. , 1992, Experimental parasitology.

[128]  J. Caulfield,et al.  Characterization of human low density lipoprotein binding proteins on the surface of schistosomula of Schistosoma mansoni. , 1992, European journal of cell biology.

[129]  R. Krauss,et al.  Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. , 1992, Atherosclerosis.

[130]  L. Wilkins An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People's Republic of China. Baseline report from the P.R.C.-U.S.A. Collaborative Study. People's Republic of China--United States Cardiovascular and Cardiopulmonary Epidemiology Research Gr , 1992 .

[131]  P. Chyou,et al.  Prospective study of serum cholesterol and site-specific cancers. , 1992, Journal of clinical epidemiology.

[132]  J. S. Owen,et al.  Characteristics of the binding of human and bovine high-density lipoproteins by bloodstream forms of the African trypanosome, Trypanosoma brucei brucei. , 1992, Biochimica et biophysica acta.

[133]  W. Willett,et al.  A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.

[134]  H. Tyroler,et al.  Changes in plasma lipid and lipoprotein cholesterol and weight prior to the diagnosis of cancer. , 1991, Cancer research.

[135]  K. Widhalm,et al.  Intestinal worm burden and serum cholesterol or lipid concentration in a Shipibo population (Peru). , 1991, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

[136]  H. El-Naggar,et al.  Axenic growth in vitro of Ancylostoma duodenale to the filariform (resting) larvae. , 1991, Journal of the Egyptian Society of Parasitology.

[137]  V. Clavey,et al.  Lipid traffic between high density lipoproteins and Plasmodium falciparum-infected red blood cells , 1991, The Journal of cell biology.

[138]  O. Akinkugbe Epidemiology of cardiovascular disease in developing countries. , 1990, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[139]  J. McNamara,et al.  Triglyceride measurements: a review of methods and interferences. , 1990, Clinical chemistry.

[140]  F. Field,et al.  Regulation of cholesterol metabolism in the intestine. , 1990, Gastroenterology.

[141]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.

[142]  P. Nilsson-ehle,et al.  Changes in plasma lipoproteins in acute malaria , 1990, Journal of internal medicine.

[143]  S. Djoumessi Serum lipids and lipoproteins during malaria infection. , 1989, Pathologie-biologie.

[144]  N. Fidge,et al.  Identification of a multispecific lipoprotein receptor in adult Schistosoma japonicum by ligand blotting analyses. , 1989, Molecular and biochemical parasitology.

[145]  I. Coppens,et al.  Receptors for the host low density lipoproteins on the hemoflagellate Trypanosoma brucei: purification and involvement in the growth of the parasite. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[146]  F. Rumjanek,et al.  Evidence for the occurrence of LDL receptors in extracts of schistosomula of Schistosoma mansoni. , 1988, Molecular and biochemical parasitology.

[147]  Y. Kaneda,et al.  Lipid analysis of Giardia lamblia and its culture medium. , 1988, Annals of tropical medicine and parasitology.

[148]  R. Hoover,et al.  Site-specific analysis of total serum cholesterol and incident cancer in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. , 1988, Cancer research.

[149]  The biology of malaria parasites. Report of a WHO Scientific Group. , 1987, Parasitology.

[150]  M. Walkey,et al.  Fatty acid and cholesterol synthesis in mice infected with the tapeworm Hymenolepis microstoma , 1987, Parasitology.

[151]  P. Basch,et al.  Schistosoma mansoni: cholesterol uptake by paired and unpaired worms. , 1986, Experimental parasitology.

[152]  J. Walsh,et al.  Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. , 1986, Reviews of infectious diseases.

[153]  S. Eaton,et al.  Paleolithic nutrition. A consideration of its nature and current implications. , 1985, The New England journal of medicine.

[154]  S. Aley,et al.  Endocytosis in Entamoeba histolytica. Evidence for a unique non- acidified compartment , 1984, The Journal of experimental medicine.

[155]  A. Martínez-Palomo,et al.  Selective primary health care: strategies for control of disease in the developing world. X. Amebiasis. , 1983, Reviews of infectious diseases.

[156]  E. Onyeneke,et al.  Plasma lipid changes in human malaria. , 1983, Tropenmedizin und Parasitologie.

[157]  T. Asami SCREENING FOR HYPERCHOLESTEROLAEMIA ON BLOOD-SPOTTED FILTERPAPER , 1983, The Lancet.

[158]  D. Linstead New defined and semi-defined media for cultivation of the flagellate Trichomonas vaginalis , 1981, Parasitology.

[159]  M. Brown,et al.  Regulation of plasma cholesterol by lipoprotein receptors. , 1981, Science.

[160]  B. W. Brown The crossover experiment for clinical trials. , 1980, Biometrics.

[161]  A. Fouts,et al.  Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. , 1980, The Journal of infectious diseases.

[162]  P. N. Chhuttani,et al.  Pathogenicity of Entamoeba histolytica--effect of cholesterol on the virulence of strains of amoebae. , 1978, The Indian journal of medical research.

[163]  B. Slavin Fundamentals of Clinical Chemistry , 1977 .

[164]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.

[165]  C. F. Craig Clinical Parasitology , 1944 .

[166]  Rajeev Gupta,et al.  Review: Type 2 diabetes in India: regional disparities: , 2007 .

[167]  J. Leahy Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomized controlled trial , 2007 .

[168]  M. Marmot,et al.  Harveian Oration Health in an unequal world , 2006 .

[169]  Das,et al.  Plasma a-tocopherol, retinol, and carotenoids in children with falciparum malaria13 , 2005 .

[170]  Guobing Xu,et al.  Serum lipid concentrations and prevalence of dyslipidemia in a large professional population in Beijing. , 2005, Clinical chemistry.

[171]  J. Paolini,et al.  Ezetimibe , 2005, Clinical pharmacokinetics.

[172]  M. Shah,et al.  Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions. , 2004, Indian journal of cancer.

[173]  Elinor Miller,et al.  Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). , 2003, The American journal of cardiology.

[174]  D Bentley,et al.  Highly parallel SNP genotyping. , 2003, Cold Spring Harbor symposia on quantitative biology.

[175]  H. Tunstall-Pedoe MONICA monograph and multimedia sourcebook: world's largest study of heart disease, stroke, risk factors, and population trends 1979-2002. , 2003 .

[176]  Rachel Leach,et al.  Rethinking the “Diseases of Affluence” Paradigm: Global Patterns of Nutritional Risks in Relation to Economic Development , 2005, PLoS medicine.

[177]  Rajeev Gupta,et al.  Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur Heart Watch-2. , 2002, Indian heart journal.

[178]  S. Grundy,et al.  ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins. , 2002, Stroke.

[179]  P A Wolf,et al.  Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. , 2001, Circulation.

[180]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[181]  A. M. Amin,et al.  Changes in serum lipids of mice experimentally infected with Schistosoma mansoni. , 1997, Journal of the Egyptian Society of Parasitology.

[182]  P. van der Stuyft,et al.  [Changes in plasma lipid levels as a function of Plasmodium falciparum infection in São Tomé]. , 1996, Parasite.

[183]  D. S. Reiner,et al.  Cell biology of the primitive eukaryote Giardia lamblia. , 1996, Annual review of microbiology.

[184]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[185]  A. Menotti,et al.  Risk Factors and Mortality Patterns in the Seven Countries Study , 1994 .

[186]  D. Kaul Do human platelets possess LDL-receptor specific for Apoprotein B or cholesterol ? , 1993 .

[187]  W. H. Hannon,et al.  International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material. , 1994, Clinical chemistry.

[188]  B. Das,et al.  Altered plasma lipid pattern in falciparum malaria. , 1992, Annals of tropical medicine and parasitology.

[189]  Richard F. Thomas THE EMERGING GIANT. , 1992 .

[190]  L. Tessitore,et al.  Altered pattern of lipid metabolism in patients with lung cancer. , 1992, Oncology.

[191]  W. Biaduń [Studies of serum lipids in guinea pigs with larval ascariasis]. , 1990, Wiadomosci parazytologiczne.

[192]  S. Ghatak,et al.  Brugia malayi: status of host during different stages of infection. , 1989, Folia parasitologica.

[193]  W. J. Johnson,et al.  The selective uptake of cholesterol by the rat tapeworm Hymenolepis diminuta (Cestoda). , 1988, Comparative biochemistry and physiology. B, Comparative biochemistry.

[194]  W. J. Johnson,et al.  Studies on the mechanism of cholesterol uptake by the rat tapeworm Hymenolepis diminuta (Cestoda). , 1988, Comparative biochemistry and physiology. B, Comparative biochemistry.

[195]  F. Rumjanek,et al.  Transfer of [14C] cholesterol and its metabolites between adult male and female worms of Schistosoma mansoni. , 1986, Comparative biochemistry and physiology. B, Comparative biochemistry.

[196]  S. Xu,et al.  Culture requirements of Ascaris suum larvae using a stationary multi-well system: increased survival, development and growth with cholesterol. , 1984, Veterinary parasitology.

[197]  S. Dodu Coronary heart disease in developing countries: the threat can be averted. , 1984, WHO chronicle.

[198]  R. Krauss,et al.  Identification of multiple subclasses of plasma low density lipoproteins in normal humans. , 1982, Journal of lipid research.

[199]  S. A. Morse,et al.  Lipid and carbohydrate metabolism of Giardia lamblia. , 1981, Molecular and biochemical parasitology.

[200]  G. P. Dutta,et al.  Virulence of strains of Entamoeba histolytica to rats and the effect of cholesterol, rat caecal and hamster liver passage on the virulence of non-invasive strains. , 1971, Indian journal of experimental biology.

[201]  R. Fleischmajer [Familial hyperlipoproteinemia]. , 1969, Anais brasileiros de dermatologia.

[202]  T. Hill A text-book of oral pathology , 1949 .

[203]  T. Durant Cardio-vascular disease. , 1947, Philadelphia medicine.